Education
Undergraduate Degree:
University of Toronto, Canada
Masters of Science:
University of Toronto School of Graduate Studies, Canada
Medical School:
St. George’s University School of Medicine, Grenada, West Indies
Dermatology Residency:
University of Toronto, Canada
Certificates
American Board of Dermatology
Fellow of the Royal College of Physicians of Canada
About
Dr. Viba Malaiyandi is a board-certified dermatologist with over 5 years of experience. Prior to joining Forefront Dermatology, she practiced in Ontario, Canada. Dr. Malaiyandi specializes in the diagnosis and treatment of a variety of dermatologic conditions including, skin cancer, acne, psoriasis, and eczema. She uses a comprehensive approach to understand your concerns because treatment of these diagnoses not only has a positive impact on your skin but also your overall wellness.
Publications
1. Ejaz A, Malaiyandi V, Kim WB, Rogalska T, Alhusayen R. Validating the diagnostic code for acne
in a tertiary care dermatology centre. Eur J Dermatol 2015 Oct 1; 25(5): 469-71. Epub 2015 Oct 30. PMID: 26518997 / doi: 10.1684/ejd.2015.2606
2. Malaiyandi V, Houle MC, Skotnicki-Grant S. Airborne allergic contact dermatitis from tylosin in pharmacy compounders and cross-sensitization to macrolide antibiotics. Dermatitis 2012 Sep-Oct; 23(5):227-30. PMID: 23010831
3. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res 2007 Apr; 9(4):511-8. PMID: 17454707
4. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 2006 Oct; 15(10):1812-9. PMID: 17035386
5. Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry 2006 Apr; 11(4):400-9. PMID: 16402128
6. Malaiyandi V, Sellers EM, Tyndale RF. Implications of CYP2A6 genetic variationfor smoking behaviors and nicotine dependence. Clin Pharmacol Ther 2005 Mar; 77(3):145-58. PMID: 15735609
